Law360, Philadelphia (May 22, 2015, 7:37 PM EDT) -- Hagens Berman Sobol Shapiro LLP is fighting tooth and nail to stop a special master from questioning 31 of its clients on their decision to drop birth defect suits in Pennsylvania federal court against GlaxoSmithKline, saying the move would violate attorney-client privilege. But there is precedent for inquiries into plaintiffs firms' conduct, especially in the context of tort litigation gone awry.
The Seattle-based firm, which was sanctioned in March for bringing time-barred suits against Sanofi-Aventis SA and Grunenthal GmbH over birth defects caused by morning sickness drug thalidomide in the 1950s and 1960s, has said that the interviews would violate privilege...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!